Cargando…

Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe

BACKGROUND: HIV affects the central nervous system resulting in HIV associated neurocognitive impairment (NCI) in approximately 50% of people living with HIV. It typically affects memory, learning, working memory, fine motor skills, speed of information processing, verbal fluency and executive funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyamayaro, Primrose, Gouse, Hetta, Hakim, James, Robbins, Reuben N., Chibanda, Dixon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257139/
https://www.ncbi.nlm.nih.gov/pubmed/32471350
http://dx.doi.org/10.1186/s12879-020-05090-8
_version_ 1783540031786319872
author Nyamayaro, Primrose
Gouse, Hetta
Hakim, James
Robbins, Reuben N.
Chibanda, Dixon
author_facet Nyamayaro, Primrose
Gouse, Hetta
Hakim, James
Robbins, Reuben N.
Chibanda, Dixon
author_sort Nyamayaro, Primrose
collection PubMed
description BACKGROUND: HIV affects the central nervous system resulting in HIV associated neurocognitive impairment (NCI) in approximately 50% of people living with HIV. It typically affects memory, learning, working memory, fine motor skills, speed of information processing, verbal fluency and executive functioning cognitive domains. NCI can affect adherence to antiretroviral therapy (ART), employability, driving ability and activities of daily living. NCI is not routinely screened for in Zimbabwe, and the burden is not known in this setting. The objectives of this study were: 1) To determine NCI prevalence using a comprehensive neuropsychological battery at two primary health care clinics in Harare; 2) To assess the pattern of cognitive impairment across cognitive domains using a gold standard neuropsychological (NP) battery in HIV-positive patients compared to HIV-negative controls. METHODS: Inclusion criteria: 18 years or older; minimum 7 years education; no neurological or psychiatric disorders. HIV-positive participants were on ART for ≥3 months; HIV-negative participants had a confirmed HIV negative status in the past month. A comprehensive NP battery, functional assessments, demographic and medical history questionnaires were administered. The NP battery consisted of tests assessing memory, learning, working memory, fine motor skills, speed of information processing, verbal fluency and executive functioning. RESULTS: Two-hundred-and-thirty-one participants were recruited. Of those, 155 were HIV-positive (Female = 70%, Age M = 37.8; SD 11.2) and 76 HIV-negative (Female = 63%, Age M = 31.2; SD 9.9). HIV-positive participants were on ART for an average of 6 years. NCI was present in 49.7% HIV positive participants. Compared to HIV-negative participants, the HIV-positive group had significantly poorer scores in 5 out of 7 cognitive domains. A good level of education is negatively correlated with NCI. CONCLUSIONS: NCI prevalence in HIV-positive population Zimbabwe is consistent with global estimates. NCI persists in adults who are on ART. Routine assessment of NCI in adults attending primary care clinics using this adapted battery is therefore important so that they are identified early and are provided the necessary interventions.
format Online
Article
Text
id pubmed-7257139
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72571392020-06-07 Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe Nyamayaro, Primrose Gouse, Hetta Hakim, James Robbins, Reuben N. Chibanda, Dixon BMC Infect Dis Research Article BACKGROUND: HIV affects the central nervous system resulting in HIV associated neurocognitive impairment (NCI) in approximately 50% of people living with HIV. It typically affects memory, learning, working memory, fine motor skills, speed of information processing, verbal fluency and executive functioning cognitive domains. NCI can affect adherence to antiretroviral therapy (ART), employability, driving ability and activities of daily living. NCI is not routinely screened for in Zimbabwe, and the burden is not known in this setting. The objectives of this study were: 1) To determine NCI prevalence using a comprehensive neuropsychological battery at two primary health care clinics in Harare; 2) To assess the pattern of cognitive impairment across cognitive domains using a gold standard neuropsychological (NP) battery in HIV-positive patients compared to HIV-negative controls. METHODS: Inclusion criteria: 18 years or older; minimum 7 years education; no neurological or psychiatric disorders. HIV-positive participants were on ART for ≥3 months; HIV-negative participants had a confirmed HIV negative status in the past month. A comprehensive NP battery, functional assessments, demographic and medical history questionnaires were administered. The NP battery consisted of tests assessing memory, learning, working memory, fine motor skills, speed of information processing, verbal fluency and executive functioning. RESULTS: Two-hundred-and-thirty-one participants were recruited. Of those, 155 were HIV-positive (Female = 70%, Age M = 37.8; SD 11.2) and 76 HIV-negative (Female = 63%, Age M = 31.2; SD 9.9). HIV-positive participants were on ART for an average of 6 years. NCI was present in 49.7% HIV positive participants. Compared to HIV-negative participants, the HIV-positive group had significantly poorer scores in 5 out of 7 cognitive domains. A good level of education is negatively correlated with NCI. CONCLUSIONS: NCI prevalence in HIV-positive population Zimbabwe is consistent with global estimates. NCI persists in adults who are on ART. Routine assessment of NCI in adults attending primary care clinics using this adapted battery is therefore important so that they are identified early and are provided the necessary interventions. BioMed Central 2020-05-29 /pmc/articles/PMC7257139/ /pubmed/32471350 http://dx.doi.org/10.1186/s12879-020-05090-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Nyamayaro, Primrose
Gouse, Hetta
Hakim, James
Robbins, Reuben N.
Chibanda, Dixon
Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe
title Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe
title_full Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe
title_fullStr Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe
title_full_unstemmed Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe
title_short Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe
title_sort neurocognitive impairment in treatment-experienced adults living with hiv attending primary care clinics in zimbabwe
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257139/
https://www.ncbi.nlm.nih.gov/pubmed/32471350
http://dx.doi.org/10.1186/s12879-020-05090-8
work_keys_str_mv AT nyamayaroprimrose neurocognitiveimpairmentintreatmentexperiencedadultslivingwithhivattendingprimarycareclinicsinzimbabwe
AT gousehetta neurocognitiveimpairmentintreatmentexperiencedadultslivingwithhivattendingprimarycareclinicsinzimbabwe
AT hakimjames neurocognitiveimpairmentintreatmentexperiencedadultslivingwithhivattendingprimarycareclinicsinzimbabwe
AT robbinsreubenn neurocognitiveimpairmentintreatmentexperiencedadultslivingwithhivattendingprimarycareclinicsinzimbabwe
AT chibandadixon neurocognitiveimpairmentintreatmentexperiencedadultslivingwithhivattendingprimarycareclinicsinzimbabwe